Mount Sinai Health System

Frontiers in Oncology Distinguished Lecture

Title: Somatic Mutations In Normal Cells: The Earliest Stages Of Cancer Development

Presenter: Michael Stratton, FRS, FMedSci, FRC Path, PhD 

Faculty profile:

Join Zoom Meeting

Meeting ID: 926 3896 1334

+19294362866,,92638961334# US (New York)

Find your local number:

Dial-In Information

Dial by your location

        +1 929 436 2866 US (New York)

        +1 301 715 8592 US (Germantown)

        +1 312 626 6799 US (Chicago)

        +1 253 215 8782 US (Tacoma)

        +1 346 248 7799 US (Houston)

        +1 669 900 6833 US (San Jose)

Meeting ID: 926 3896 1334

Find your local number:

Join by SIP

Join by H.323 (US West) (US East) (India Mumbai) (India Hyderabad) (EMEA) (Australia) (Brazil) (Canada) (Japan)

Meeting ID: 926 3896 1334

Tuesday, April 13 at 12:00pm to 1:00pm

Virtual Event
Event Type

Academic, Lecture/Seminar


Alumni, Faculty, Postdocs, Students, Health Care Professionals, Prospective Faculty


Icahn School of Medicine at Mount Sinai, The Mount Sinai Hospital


Medical Education, Graduate Education, Postdoctoral Affairs, Fellowships


The Tisch Cancer Institute

Cancer Biology (CAB), Developmental and Stem Cell Biology (DSCB), Genetics and Genomic Sciences (GGS), Immunology (IMM)

Michael Stratton, FRS, FMedSci, FRC Path, PhD
Director and Chief Executive Officer
Wellcome Genome Campus
Wellcome Sanger Institute